Navigation Links
Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
Date:10/23/2008

REHOVOT, Israel and JERSEY CITY, New Jersey, October 23 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, today announced that it will present at the upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer". The event will take place from October 30 to November 1 in Hollywood, Florida.

The poster presentation, titled "MicroRNA-based identification of tumor origin", will describe Rosetta Genomics' unique microRNA-based assay designed to assist in identifying the primary tumor of origin of a metastasis.

About MicroRNA

MicroRNAs (miRNAs) are recently discovered, naturally occurring, small RNAs that act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNAs have been shown to have different expression in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
2. Rosetta Genomics Reports Second Quarter 2008 Financial Results
3. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
4. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
5. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
6. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
7. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
8. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
9. /C O R R E C T I O N -- Rosetta Genomics Ltd/
10. Rosetta Genomics Reports First Quarter 2008 Financial Results
11. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...irstCall/ -- Lixte Biotechnology Holdings (OTC Bul...ors of the National Institute of Neurological Diso...nstitute (NCI), National Institutes of Health and ...hances the effectiveness of two standard chemother...esearch is being conducted under a Cooperative Res...
(Date:7/1/2009)... WuXi PharmaTech (Cayman) Inc.,(NYSE: WX ) anno...F for,excellent service and outstanding contribut...-protection active ingredients. , (Logo: h...LOGO ) , "We had been looking for a good C...hink we have found one, a top-notch partner," Dr. ...
(Date:7/1/2009)...in Air Force History Appointed to Highest Noncommi... 1 MicroTech announce...Air Force (CMSAF) Rod McKinley has joined the comp...tnerships. MicroTech is one of the fastest growin...n the U.S. In his new role, McKinley will provide ...
(Date:7/1/2009)...- NeoStem, Inc. (NYSE Amex: NBS ) announced toda...r $4 million from institutional and private invest...ivate placement from three Asia-based investors an... obtained by NeoStem in the past two and half mont...f Suzhou Erye Pharmaceuticals Company, Ltd. have i...
Breaking Biology Technology:Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 2Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 3WuXi PharmaTech Receives Award from BASF 2Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 2Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 3NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3
..., Introduction , , The ...fied with fluorescence spectroscopy. This is of si... companies that manufacture hair creams, coloring,...xperiment and Results , For customers invo...wing evaluation using fluorescence spectroscopy. T...
..., Introduction , Automobile-parts prod...lvanizing (EV) bath line. Because a sensitive and ...o productivity, quality, and identification of err...the source of error and contribute to selecting th...herefore can be minimized. <P,>Fluorescence spec...
... Reduced-Volume Samples , 20 L, 50 L, 250 L, or...nzymes polymers amino acids ,<P ,> Ma...rb imaging quality <P ,>Samples can be valua...y not have very much with which to start. Biologic...tained in small volumes and may be expensive. On t...
... , By Linda E. Cammish, Ph.D., NextGen S...er Life Sciences, Inc. , Introduction ,...esearch and drug discovery has become very widespr...hat are the vast majority of the true drug targets...e of functional protein microarrays, sometimes ref...
Other Biology Technology:Assessing UV damage of hair 2Characterizing galvanizing baths 2Characterizing galvanizing baths 3New Tools for Making and Processing Protein Microarrays. 2New Tools for Making and Processing Protein Microarrays. 3New Tools for Making and Processing Protein Microarrays. 4New Tools for Making and Processing Protein Microarrays. 5New Tools for Making and Processing Protein Microarrays. 6New Tools for Making and Processing Protein Microarrays. 7New Tools for Making and Processing Protein Microarrays. 8New Tools for Making and Processing Protein Microarrays. 9
(Date:7/2/2009)..., N.C. -- As flowering plants like giant trees qui... Cretaceous period, the ferns that had preceded th... they flourished. While modern tropical rain fores..., and experienced a flowering of their own species...- diversification," said Duke University researche...
(Date:7/1/2009)..., 1 July, 2009 Johnson & Johnson today announced ...nt of Molecular Biology at the Max Planck Institut...ve led to novel cancer therapies including Hercept...aul Janssen Award for Biomedical Research. An ind...lected Dr. Ullrich, who on September 8 will receiv...
(Date:7/1/2009)...archers from the Department of Science Education-B...ged to make out the "self-irrigating" mechanism of...6 times the amount of water than otherwise expecte...es of rain in the desert. This is the first exampl...sert rhubarb grows in the mountains of Israel,s Ne...
(Date:7/1/2009)...onding to scientists, need to measure organic cont...ute of Standards and Technology (NIST) has recentl...) available for purchase. Developed in collaborati...tion (CDC), the human milk and serum SRMs have cer...ardants and pesticides, commonly found in the U.S....
Breaking Biology News(10 mins):Ferns took to the trees and thrived 2Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Desert rhubarb -- a self-irrigating plant 2NIST issues human milk and blood serum SRMs for contaminant measurements 2Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 1Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 2Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 3Helping Families Cope After an Injury 1342 1Helping Families Cope After an Injury 1342 2Divided We Fail to Ramp Up Efforts Leading Up to Maryland Primary 11328 1Divided We Fail to Ramp Up Efforts Leading Up to Maryland Primary 11328 2Divided We Fail to Ramp Up Efforts Leading Up to Maryland Primary 11328 3Physics breakthroughs on tap at New Orleans conference 11325 1Physics breakthroughs on tap at New Orleans conference 11325 2
...nical trial to test different strengths of a vacci...is month at Duke University Medical Center. , The ...l test a modified form of an investigational bird ... triggers a strong immune response at lower doses....ional Institute of Allergy and Infectious Diseases...
...dy by researchers at the University of California,...t the rate of HIV/AIDS infection in Tijuana, Mexic...viously estimated. The findings are based on data...Diego and Mexico to create a population-based mode... number of men and women aged 15 to 49 years who a...
...e frog that lives in rushing streams and waterfall...rd above the roar of flowing water by communicatin...the journal Nature. Attributes that enable the fro...sence of an ear canal, which most other frogs don,...novel solution to the problem of communication in ...
...ternational research team has provided the first c...rs such as mental retardation and neurodegenerativ...,s disease and ataxias can be caused, at least in ... the electrical impulses of rapid-firing brain ner... gene, KCNC3, and two mutations are described in t...
Other Biology News:Duke to test bird flu vaccine dosing 2HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate 2HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate 3Frog’s ear canal may provide insights for understanding human hearing loss 2Frog’s ear canal may provide insights for understanding human hearing loss 3Study ties 'new' cell-death mechanism to developmental and degenerative brain disorders 2Study ties 'new' cell-death mechanism to developmental and degenerative brain disorders 3
Acetylcholinesterase (human brain, AChE)
...eets the demands of the routine trace metal analyt...le, robust and simple to use instrumentation. The ...t challenging sample matrices found in the environ...est analytical challenges found in the clinical, f...
C1-inhibitor (C1-INH)
Polio component type I
Biology Products: